Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: i pose a question, that may or maynot be easy to answer ,

this is your opinion, not mine. the stock began its slide after the dividends and the sony deal....and licensing at that time was strong. the J3, "we are happy with the resolution" statement released by PTSC did not move the stock upwards. we continued to slide even with the licensing. money in the treasury would move us upward, but the BOD's managment of that money has been a disaster. and they are still in charge and have yet to prove they deserve their poisitions on the BOD. do you not remember that when PTSC did release a pr of a license that we did not trade upwards.

i really am not intested in debating the worth of the BOD. I do realize that the BOD has nothing to do with licensing. So with that said, exactly what is their function to be paid $100k a year? Managing the revenues. Have they done well. No.

teremoto

Share
New Message
Please login to post a reply